首页 > 市场调查报告书 > 医疗设备

心血管设备

市场调查报告书

商品编码

1550646

冠状动脉绕道手术手术市场：依技术、依产品、依最终用户、按地区

Coronary Artery Bypass Grafting Market, By Technology, By Product, By End User, By Geography

出版日期: 2024年08月05日 | 出版商:

Coherent Market Insights | 英文 165 Pages | 商品交期: 2-3个工作天内

价格

简介目录

预计2024年全球冠状动脉绕道手术手术市场规模为140.2亿美元，预计2031年将达261.5亿美元，2024年至2031年复合年增长率为9.3%。

报告范围		报告详情
基准年	2023年	2024年市场规模	140.2亿美元
实际资料	2019-2023	预测期	2024年至2031年
预测 2024-2031 年复合年增长率：	9.30%	2031年价值预测	261.5亿美元

图：2024 年按地区分類的冠状动脉绕道手术手术市场占有率(%)

冠状动脉绕道手术手术（CABG）是一种改善心臟血流的手术。 CABG 用于治疗其他治疗方法不足以治疗的严重冠状动脉疾病。手术的主要目标是用健康的血管（通常来自患者的胸部、手臂或腿部）绕过狭窄或阻塞的冠状动脉。这可以改善心肌的血流量和氧气供应，缓解胸痛和胸闷（心绞痛）的症状，并降低心臟病发作的风险。冠状动脉绕道手术手术是全世界最常进行的心血管手术之一。

市场动态：.

冠状动脉绕道手术手术的全球市场成长是由新兴市场和已开发市场心臟病盛行率不断上升所推动的。高血压、糖尿病、肥胖和缺乏运动正在增加心血管疾病患者的数量，并推动了冠状动脉绕道手术的需求。已开发国家对心臟治疗的优惠报销政策和新兴经济体医疗旅游业的成长可以为市场成长提供机会。然而，冠状动脉重组的创新微创血管内治疗方法的市场开拓可能会阻碍市场成长，因为与心臟直视手术相比，它们的併发症更少，恢復更快。市场参与企业可以透过整合机器人技术和导航技术来克服这一限制，使 CABG 更安全、更简单。

本研究的主要特点

本报告对全球冠状动脉绕道手术手术市场进行了详细分析，包括以2023年为基准年的预测期（2024-2031年）的市场规模（十亿美元）和年复合成长率（CAGR%）。做。

它还揭示了各个细分市场的潜在商机，并为该市场说明了一系列有吸引力的投资提案。

它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要见解。

根据公司亮点、产品系列、主要亮点、绩效和策略等参数，包括全球冠状动脉绕道手术手术市场的主要企业概况。

主要企业包括美敦力 (Medtronic)、泰尔茂 (Terumo)、MAQUET、波士顿科学 (Boston Scientific)、CR Bard、Edwards Lifesciences 等。

从这份报告中获得的见解将帮助负责人和公司经营团队就未来的产品发布、升级、市场扩张和行销策略做出明智的决策。

全球冠状动脉绕道手术手术市场报告迎合了该行业的各种相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。

透过用于分析全球冠状动脉绕道手术手术市场的各种策略矩阵，将有助于相关人员做出决策。

公司简介
- Abbott Laboratories
- Medtronic
- Boston Scientific Corporation
- LivaNova PLC
- Edwards Lifesciences Corporation
- Maquet Holding BV &Co. KG
- TERUMO CORPORATION
- Guidant
- Vitalitec
- Novadaq
- KARL STORZ
- Ethicon US, LLC（Johnson &Johnson）
- NeoGraft Technologies, Inc.
- Genesee Biomedical Inc.
- Hancock Jaffe Laboratories, Inc.
- VasoPrep Surgical
- Dextera Surgical Inc.
- Neograft Inc.

第10章分析师建议

命运之轮
分析师观点
一致的机会图

第十一章参考文献与调查方法

参考
调查方法

简介目录

Product Code: CMI7225

Global coronary artery bypass grafting market is estimated to be valued at USD 14.02 Bn in 2024 and is expected to reach USD 26.15 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 9.3% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2024:	US$ 14.02 Bn
Historical Data for:	2019 to 2023	Forecast Period:	2024 to 2031
Forecast Period 2024 to 2031 CAGR:	9.30%	2031 Value Projection:	US$ 26.15 Bn

Figure. Coronary Artery Bypass Grafting Market Share (%), By Region 2024

Coronary Artery Bypass Grafting Market - IMG1

Coronary artery bypass grafting (CABG) is a type of surgery that improves blood flow to the heart. It is used to treat people with severe coronary artery disease that has not responded well to other treatments. The main purpose of the surgery is to bypass narrow or blocked sections of the coronary arteries with healthy blood vessels, usually taken from the chest, arm, or leg of the patient. This improves blood flow and oxygen delivery to the heart muscle, thus, relieving symptoms of chest pain or pressure (angina) and reducing the risk of heart attack. Coronary artery bypass grafting is one of the most commonly performed cardiac surgeries worldwide.

Market Dynamics:

Global coronary artery bypass grafting market growth is driven by increasing prevalence of heart disease across both developing and developed nations. High blood pressure, diabetes, obesity and lack of physical activity has increased cardiovascular cases, thus, boosting demand for CABG procedures. Favorable reimbursement policies for cardiac treatments in developed countries and growing medical tourism in emerging economies can offer opportunities for market growth. However, development of innovative minimally invasive endovascular techniques for coronary revascularization can hamper the market growth as these result in less complications and faster recovery times as compared to open-chest CABG surgery. The market players could overcome this restraint by integrating robotic and navigation technologies to make CABG safer and less complex.

Key Features of the Study:

This report provides in-depth analysis of the global coronary artery bypass grafting market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global coronary artery bypass grafting market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Medtronic, Terumo, MAQUET, Boston Scientific, C. R. Bard and Edwards Lifesciences

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

Global coronary artery bypass grafting market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global coronary artery bypass grafting market

Detailed Segmentation-

By Technology
- Off-pump CABG
- On-pump CABG
- Others
By Product
- Grafts
- Saphenous vein grafts
- Internal thoracic artery grafts
- Other grafts
- Retractors
- Heart positioners
- Tissue stabilizers
- Others
By End User
- Hospitals
- Cardiology Clinics
- Ambulatory surgical centers
- Academic & Research institute
- Other
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Abbott Laboratories
- Medtronic
- Boston Scientific Corporation
- LivaNova PLC
- Edwards Lifesciences Corporation
- Maquet Holding B.V. & Co. KG
- TERUMO CORPORATION
- Guidant
- Vitalitec
- Novadaq
- KARL STORZ
- Ethicon US, LLC (Johnson & Johnson)
- NeoGraft Technologies, Inc.
- Genesee Biomedical Inc.
- Hancock Jaffe Laboratories, Inc.
- VasoPrep Surgical
- Dextera Surgical Inc.
- Neograft Inc.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Technology
- Market Snapshot, By Product
- Market Snapshot, By End User
- Market Snapshot, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Scenario
Acquisitions and Partnerships Scenario
Funding and Investments
PEST Analysis
Porter's Analysis

4. Global Coronary Artery Bypass Grafting Market- Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 Impact on the Market

5. Global Coronary Artery Bypass Grafting Market, By Technology, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Off-pump CABG
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
On-pump CABG
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Coronary Artery Bypass Grafting Market, By Product, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Grafts
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Saphenous vein grafts
Internal thoracic artery grafts
Other grafts
Retractors
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Heart positioners
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Tissue stabilizers
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Coronary Artery Bypass Grafting Market, By End User, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Hospitals
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Cardiology Clinics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Ambulatory surgical centers
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Academic & Research institute
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Coronary Artery Bypass Grafting Market, By Region, 2019 - 2031, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2019-2031
- Regional Trends
  - North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USDBn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USDBn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USDBn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USDBn)
  - GCC Countries
  - Israel
  - Rest of Middle East
  - Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USDBn)
  - North Africa
  - Central Africa
  - South Africa

9. Competitive Landscape

Company Profiles
- Abbott Laboratories
  - Company Highlights
  - Method Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Medtronic
  - Company Highlights
  - Method Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Boston Scientific Corporation
  - Company Highlights
  - Method Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- LivaNova PLC
  - Company Highlights
  - Method Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Edwards Lifesciences Corporation
  - Company Highlights
  - Method Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Maquet Holding B.V. & Co. KG
  - Company Highlights
  - Method Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- TERUMO CORPORATION
- Guidant
- Vitalitec
- Novadaq
- KARL STORZ
- Ethicon US, LLC (Johnson & Johnson)
- NeoGraft Technologies, Inc.
- Genesee Biomedical Inc.
- Hancock Jaffe Laboratories, Inc.
- VasoPrep Surgical
- Dextera Surgical Inc.
- Neograft Inc.

10. Analyst Recommendations

Wheel of Fortune
Analyst View
Coherent Opportunity Map

11. References and Research Methodology

References
Research Methodology
About us and Sales Contact

02-2729-4219

+886-2-2729-4219

License/价格

冠状动脉绕道手术手术市场：依技术、依产品、依最终用户、按地区